Marla Dubinsky, MD, Discusses Patient Success with Dashboard-Guided Infliximab Induction in Gastroenterology & Endoscopy News Article Baysient’s patented iDose system uses Bayesian models, laboratory data, and demographics to individualize Infliximab dosing, effectively improving inflammatory bowel disease (IBD) patient outcomes. Marla…
For many years, Crohn’s disease and IBD went widely misunderstood and unrecognized. In fact, early doctors could not differentiate between IBD and diarrheal diseases caused by infectious agents. It wasn’t until 1932 that Crohn’s disease was initially described in detail,…
When it comes to drug therapy, there is no one right dose for all patients. Each patient is unique and deserves individual treatments tailored specifically for them. Precision dosing has been shown to have significant benefits by improving patient outcomes,…
Marla Dubinsky, MD, Speaks on Proactive Therapeutic Monitoring During a recent podcast on Podcasts360, Marla Dubinsky, MD, discussed how her research on measuring drug concentrations and anti-drug antibodies along with algorithmic approaches to proactive therapeutic drug monitoring could help patients…
Medication plays an essential role in healthcare, but it also is a significant element in the increasing cost of health care. Precision dosing, also referred to as individualized dosing, utilizes drug attributes, disease state characteristics, and patient-specific factors to optimize…
At Baysient, it is our mission to help patients achieve remission from their inflammatory diseases. The traditional dosing process for such conditions leads to expensive medical costs overall and makes long-term remission challenging to achieve and maintain. Through precision and…
Inflammatory Bowel Disease (IBD) represents a group of chronic intestinal conditions, such as ulcerative colitis and Crohn’s disease. These disorders cause prolonged inflammation in the digestive tract, leading to uncomfortable and sometimes unpredictable symptoms. Living with IBD can be a…
Baysient’s revolutionary iDose software calculates a precise, model-informed dose of medication to help patients reach, and stay in, remission. We understand that all patients are unique and deserve customized therapies to drive improved treatment outcomes. iDose works by calculating treatment…
Coronavirus (COVID-19) is officially a worldwide pandemic as it continues to spread globally. The doctors and researchers on the Baysient team are actively developing treatments for COVID-19 to help end the death toll it has caused around the world. For…
Ft. Myers FL, February 28, 2020 - Baysient® LLC’s founder, Diane Mould, announces the release of the iDose® software technology platform version 1.0 for infliximab (an anti-inflammatory biologic drug), just before presenting Biologics and Precision Medicine in IBD at Canadian Digestive…
